Pipeline Programs↗
Active Trials↗
Companies Involved↗
Fracture is a moderately active landscape with 45 programs across 36 companies. 5 programs are in Phase 3.
Intelligence
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Analysis
98%
Small molecule
42 of 43 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 43 classified programs, each share of the total. Modality classified for 100% of 45 pipeline programs.
Analysis
394
clinical trials
Clinical Trials
394 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)